Robert Adams to Anemia, Sickle Cell
This is a "connection" page, showing publications Robert Adams has written about Anemia, Sickle Cell.
Connection Strength
10.801
-
Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
Score: 0.601
-
New approaches to genetic predisposition for hemorrhagic stroke in sickle cell disease. J Clin Hypertens (Greenwich). 2018 06; 20(6):1078-1079.
Score: 0.474
-
Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke. Stroke. 2017 03; 48(3):686-691.
Score: 0.433
-
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016 Feb 13; 387(10019):661-670.
Score: 0.399
-
Neurologic complications of sickle cell disease. Handb Clin Neurol. 2014; 120:1015-25.
Score: 0.349
-
Prevention of stroke in sickle cell anemia. J Law Med Ethics. 2014; 42(2):135-8.
Score: 0.349
-
Toward a stroke-free childhood in sickle cell disease: the 2013 Sherman Lecture. Stroke. 2013 Oct; 44(10):2930-4.
Score: 0.341
-
Trends in comorbid sickle cell disease among stroke patients. J Neurol Sci. 2012 Feb 15; 313(1-2):86-91.
Score: 0.299
-
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8.
Score: 0.258
-
Big strokes in small persons. Arch Neurol. 2007 Nov; 64(11):1567-74.
Score: 0.228
-
Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease. Pediatr Blood Cancer. 2007 Sep; 49(3):318-22.
Score: 0.225
-
Transcranial Doppler ultrasonography in adults with sickle cell disease. Neurology. 2006 Aug 22; 67(4):572-4.
Score: 0.210
-
Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006 Jun; 5(6):501-12.
Score: 0.206
-
Trials in sickle cell disease. Pediatr Neurol. 2006 Jun; 34(6):450-8.
Score: 0.206
-
Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke. 2006 Jun; 37(6):1424-6.
Score: 0.205
-
Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005 Dec 29; 353(26):2769-78.
Score: 0.200
-
TCD in sickle cell disease: an important and useful test. Pediatr Radiol. 2005 Mar; 35(3):229-34.
Score: 0.189
-
Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72.
Score: 0.185
-
Sickle cell disease: primary stroke prevention. CNS Spectr. 2004 Jun; 9(6):445-9.
Score: 0.180
-
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
Score: 0.175
-
Sickle cell disease and stroke: primary prevention and transcranial Doppler. Ann Neurol. 2003 Nov; 54(5):559-63.
Score: 0.173
-
Hemorrhagic Stroke in Children and Adults With Sickle Cell Anemia: The Post-STOP Cohort. Stroke. 2022 11; 53(11):e463-e466.
Score: 0.160
-
Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia. J Pediatr Hematol Oncol Nurs. 2022 Jul-Aug; 39(4):209-220.
Score: 0.154
-
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.
Score: 0.147
-
Stroke prevention and treatment in sickle cell disease. Arch Neurol. 2001 Apr; 58(4):565-8.
Score: 0.144
-
Sickle cell and the brain. Hematology Am Soc Hematol Educ Program. 2001; 31-46.
Score: 0.142
-
Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol. 2000 Nov; 30(11):733-8.
Score: 0.140
-
Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium. Pediatr Blood Cancer. 2020 11; 67(11):e28569.
Score: 0.139
-
Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9.
Score: 0.137
-
Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol. 2000 May; 15(5):344-9.
Score: 0.135
-
Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172.
Score: 0.133
-
Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era. Am J Hematol. 2019 12; 94(12):1335-1343.
Score: 0.131
-
Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials. 2019 02; 16(1):20-31.
Score: 0.122
-
Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease. Am J Hematol. 2018 09; 93(9):E222-E224.
Score: 0.120
-
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
Score: 0.119
-
Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition. Br J Haematol. 2018 04; 181(2):242-251.
Score: 0.117
-
Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
Score: 0.116
-
Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997 Nov; 42(5):699-704.
Score: 0.114
-
Internal carotid artery occlusion in a child with sickle cell disease: case report and immunohistochemical study. J Pediatr Hematol Oncol. 1997 Sep-Oct; 19(5):455-8.
Score: 0.113
-
Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Am J Hematol. 2016 12; 91(12):1191-1194.
Score: 0.106
-
TCD in sickle cell disease. J Pediatr Hematol Oncol. 1996 Aug; 18(3):331-4.
Score: 0.104
-
Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012. Public Health Rep. 2016 Jan-Feb; 131(1):108-16.
Score: 0.100
-
Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke. PLoS One. 2015; 10(8):e0134193.
Score: 0.098
-
Sickle cell disease and stroke. J Child Neurol. 1995 Mar; 10(2):75-6.
Score: 0.095
-
Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents. Clin Pediatr (Phila). 1994 Sep; 33(9):517-24.
Score: 0.091
-
Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood. 2014 Aug 07; 124(6):891-8.
Score: 0.090
-
Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994 Apr; 45(4):279-82.
Score: 0.089
-
Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk. Am J Hematol. 2014 Jan; 89(1):47-51.
Score: 0.087
-
Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
Score: 0.085
-
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013 Apr 18; 121(16):3237-45.
Score: 0.082
-
Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992 Aug; 23(8):1073-7.
Score: 0.079
-
Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia. Cytokine. 2012 Oct; 60(1):302-8.
Score: 0.078
-
Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
Score: 0.073
-
Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood. 2011 Jul 28; 118(4):894-8.
Score: 0.073
-
Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
Score: 0.072
-
Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Pediatr Blood Cancer. 2011 May; 56(5):777-82.
Score: 0.071
-
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer. 2010 Feb; 54(2):256-9.
Score: 0.067
-
Cerebral vessel stenosis in sickle cell disease: criteria for detection by transcranial Doppler. Am J Pediatr Hematol Oncol. 1990; 12(3):277-82.
Score: 0.066
-
Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease. Cytokine. 2010 Jan; 49(1):39-44.
Score: 0.065
-
Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology. 2009 Apr 14; 72(15):1316-21.
Score: 0.063
-
MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer. 2008 Nov; 51(5):643-6.
Score: 0.061
-
Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology. 1988 Jul; 38(7):1012-7.
Score: 0.060
-
Detection of cerebral vasculopathy in sickle cell disease using transcranial Doppler ultrasonography and magnetic resonance imaging. Case report. Stroke. 1988 Apr; 19(4):518-20.
Score: 0.059
-
Obstacles to primary stroke prevention in children with sickle cell disease. Neurology. 2006 Sep 26; 67(6):1098-9.
Score: 0.053
-
Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br J Haematol. 2006 Aug; 134(3):333-9.
Score: 0.052
-
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 2006 Aug 01; 108(3):847-52.
Score: 0.052
-
Stroke in sickle cell disease. J Med Assoc Ga. 1986 May; 75(5):271-4.
Score: 0.051
-
Declining stroke rates in Californian children with sickle cell disease. Blood. 2004 Jul 15; 104(2):336-9.
Score: 0.044
-
Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004 Apr 01; 103(7):2822-6.
Score: 0.044
-
Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol. 2003 Aug; 25(8):622-8.
Score: 0.042
-
Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med Genet. 2003 Jul 18; 4:6.
Score: 0.042
-
Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001 Dec; 58(12):2017-21.
Score: 0.038
-
Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
Score: 0.038
-
Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001 Sep; 41(9):1086-92.
Score: 0.037
-
Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell disease. Blood. 2001 Jun 01; 97(11):3401-4.
Score: 0.036
-
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
Score: 0.024
-
Sickle cell anemia and other hemoglobinopathies. Semin Neurol. 1991 Dec; 11(4):314-28.
Score: 0.019
-
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Jan; 42(1):227-76.
Score: 0.017
-
Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. J Assoc Acad Minor Phys. 1990; 1(3):79-82.
Score: 0.017
-
MR and CT investigation of cerebrovascular disease in sickle cell patients. AJNR Am J Neuroradiol. 1986 Nov-Dec; 7(6):1043-9.
Score: 0.013